Skip to main content

Table 2 Demogrphic features of SAH group, control group and treatment of patients

From: Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm

Male (%)

8 (52.9)

Female (%)

6 (47.1)

Mean age

53.46 (26–77)

Hypertension (%)

15 (44.1)

Diabetes mellitus (%)

7 (20.6)

Vasospasm (%)

11 (34.1)

Subarachnoid hemorrhage

27 (79.4%)

Elective aneurysms clipping (without SAH)

7 (20.6 %)

Aneursymal clipping

25

Endovasculer coilling

1

Medical therapy

9

Patients with SAH without aneurysyms

6